We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance

Results:1-10 of 371

Kevin Casey McAvey
  • Manatt Phelps & Phillips LLP

Anne P. Sharamitaro
  • Bryan Cave Leighton Paisner (Bryan Cave)

Jodi G. Daniel
  • Crowell & Moring LLP

OIG Report Highlights Impact of Improper Drug Classification
  • Arent Fox LLP
  • USA
  • January 12 2018

In late December 2017, the Office of Inspector General (OIG) of the Department of Health and Human Services (HHS) released the findings of a report

Jennifer P. Whitton
  • Baker & Hostetler LLP

Rachel E. Yount
  • Arent Fox LLP

Charlotte A. Combre
  • Baker & Hostetler LLP

OIG Approves Pharmacy’s Benefit Program
  • Greenberg Traurig LLP
  • USA
  • September 14 2017

The Office of Inspector General for the U.S. Department of Health & Human Services (OIG) recently issued Advisory Opinion 17-05, in which it approved